SEC Form D private-offering filing

Odyssey Therapeutics, Inc.

Name: Odyssey Therapeutics, Inc. - new SEC Form D private-offering filing, Boston, MA
Published: 2025-12-04

A new SEC Form D private-offering notice from Boston, MA, a $214,025,200 filer-stated offering target in Biotech. The source filing is one click away.

Odyssey Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing small molecule and protein therapeutics for autoimmune and inflammatory diseases, targeting the innate immune system

Filed 2025-12-04Filed to raise $214,025,200First money in 2025-06-16Raised so far $214,025,200HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) LateCall status Late filing

Source linked the Form D on EDGAR↗Website verified odysseytx.com↗Named in the filing 14 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.